Postoperative adjuvant radiochemotherapy with cisplatin versus adjuvant radiochemotherapy with cisplatin and pembrolizumab in locally advanced head and neck squamous cell carcinoma- the study protocol of the Adrisk trial

Most of the patients with head and neck squamous cell carcinoma (HNSCC) are diagnosed with locally advanced disease. Standards of care for curative-intent treatment of this patient group are either surgery and adjuvant radio(chemo)therapy (aRCT) or definitive chemoradiation. Despite these treatments...

Descripción completa

Detalles Bibliográficos
Autores principales: Wiegand, Susanne, Wichmann, Gunnar, Vogt, Jeannette, Vogel, Kathrin, Franke, Annegret, Kuhnt, Thomas, Lordick, Florian, Scheuble, Anne-Marie, Hambsch, Peter, Brossart, Peter, Bauernfeind, Franz Georg, Kaftan, Holger, Maschmeyer, Georg, Paland, Matthias, Münter, Marc, Lewitzki, Victor, Rotter, Nicole, Stromberger, Carmen, Beck, Marcus, Dommerich, Steffen, Gauler, Thomas Christoph, Hapke, Gunnar, Guntinas-Lichius, Orlando, Schröder, Ursula, Görner, Martin, Hautmann, Matthias G., Steger, Felix, Tamaskovics, Bálint, Schmiedeknecht, Anett, Dietz, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10071022/
https://www.ncbi.nlm.nih.gov/pubmed/37025596
http://dx.doi.org/10.3389/fonc.2023.1128176

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10071022/
https://www.ncbi.nlm.nih.gov/pubmed/37025596
http://dx.doi.org/10.3389/fonc.2023.1128176

Ejemplares similares